193
Views
13
CrossRef citations to date
0
Altmetric
Short Communication

C-reactive protein, platelets, and patent ductus arteriosus

, , , , &
Pages 821-823 | Received 13 Mar 2016, Accepted 01 Jun 2016, Published online: 27 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Birol Karabulut & Baran Cengiz Arcagök. (2021) Utility of the Platelet-to-Lymphocyte Ratio in Diagnosing and Predicting Treatment Success in Preterm Neonates with Patent Ductus Arteriosus. Fetal and Pediatric Pathology 40:2, pages 103-112.
Read now

Articles from other publishers (12)

Hannes Sallmon & Cassidy A. Delaney. (2023) Platelets and ductus arteriosus closure in neonates. Seminars in Perinatology 47:2, pages 151719.
Crossref
Moreyba Borges-Lujan, Gema E. Gonzalez-Luis, Tom Roosen, Maurice J. Huizing & Eduardo Villamor. (2022) Sex Differences in Patent Ductus Arteriosus Incidence and Response to Pharmacological Treatment in Preterm Infants: A Systematic Review, Meta-Analysis and Meta-Regression. Journal of Personalized Medicine 12:7, pages 1143.
Crossref
Yuchen Yang, Juan Li & Jian Mao. (2022) Early diagnostic value of C-reactive protein as an inflammatory marker for moderate-to-severe bronchopulmonary dysplasia in premature infants with birth weight less than 1500 g. International Immunopharmacology 103, pages 108462.
Crossref
Hsiao-Wen Huang, Chih Lin, Kai-Hsiang Hsu, Shih-Yun Hsu, Tze-Yee Mok, I-Hsyuan Wu, Mei-Yin Lai & Reyin Lien. (2021) Protective factors against preterm infants to develop significant patent ductus arteriosus. Pediatrics & Neonatology 62:4, pages 379-386.
Crossref
Hannes Sallmon, Natalie Timme, Begüm Atasay, Ömer Erdeve, Georg Hansmann, Yogen Singh, Sven C. Weber & Elaine L. Shelton. (2021) Current Controversy on Platelets and Patent Ductus Arteriosus Closure in Preterm Infants. Frontiers in Pediatrics 9.
Crossref
Gema González-Luis, Stefano Ghirardello, Pilar Bas-Suárez, Giacomo Cavallaro, Fabio Mosca, Ronald I Clyman & Eduardo Villamor. (2021) Platelet Counts and Patent Ductus Arteriosus in Preterm Infants: An Updated Systematic Review and Meta-Analysis. Frontiers in Pediatrics 8.
Crossref
Flaminia Bardanzellu, Cristina Piras, Alessandra Atzei, Paola Neroni & Vassilios Fanos. (2020) Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data. Frontiers in Pediatrics 8.
Crossref
Hannes Sallmon, Boris Metze, Petra Koehne, Bernd Opgen-Rhein, Katja Weiss, Joachim C. Will, Christina Victoria Franke, Georg Hansmann, Martin Koestenberger, Christoph Bührer, Felix Berger, Sven C. Weber & Malte Cremer. (2020) Mature and immature platelets during the first week after birth and incidence of patent ductus arteriosus. Cardiology in the Young 30:6, pages 769-773.
Crossref
Kiran More & Samir Gupta. 2020. Emerging Topics and Controversies in Neonatology. Emerging Topics and Controversies in Neonatology 239 258 .
Buse Özer Bekmez, Cüneyt Tayman, Mehmet Büyüktiryaki, Aslıhan Köse Çetinkaya, Ufuk Çakır & Turan Derme. (2018) A promising, novel index in the diagnosis and follow‐up of patent ductus arteriosus: Red cell distribution width‐to‐platelet ratio. Journal of Clinical Laboratory Analysis 32:9.
Crossref
M. Kluckow & P. Lemmers. (2018) Hemodynamic assessment of the patent ductus arteriosus: Beyond ultrasound. Seminars in Fetal and Neonatal Medicine 23:4, pages 239-244.
Crossref
Flaminia Bardanzellu, Paola Neroni, Angelica Dessì & Vassilios Fanos. (2017) Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?. BioMed Research International 2017, pages 1-25.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.